Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,144 | -31,632 | -12,648 | -9,666 | -5,753 |
| Depreciation Amortization | 449 | 399 | 198 | 30 | 17 |
| Other Working Capital | 1,438 | -2,183 | -420 | 640 | -69 |
| Other Operating Activity | 5,023 | 3,579 | 1,412 | 1,522 | 1,363 |
| Operating Cash Flow | $-29,234 | $-29,837 | $-11,458 | $-7,474 | $-4,442 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,500 | N/A | N/A | N/A | N/A |
| PPE Investments | -116 | -63 | -394 | -56 | -20 |
| Purchase Of Investment | -183,765 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 77,844 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -35 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -35 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-110,572 | $-63 | $-394 | $-56 | $-20 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 131 |
| Debt Issued | N/A | N/A | N/A | N/A | 29,792 |
| Common Stock Issued | 83,201 | 77,189 | 37,993 | 232 | 586 |
| Other Financing Activity | 394 | -1,230 | -1,030 | -815 | -2,450 |
| Financing Cash Flow | $83,595 | $75,959 | $36,963 | $-583 | $28,059 |
| Exchange Rate Effect | -269 | 9 | -366 | -161 | 4 |
| Beginning Cash Position | 88,157 | 42,089 | 17,344 | 25,618 | 2,017 |
| End Cash Position | 31,677 | 88,157 | 42,089 | 17,344 | 25,618 |
| Net Cash Flow | $-56,480 | $46,068 | $24,745 | $-8,274 | $23,601 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,234 | -29,837 | -11,458 | -7,474 | -4,442 |
| Capital Expenditure | -116 | -63 | -394 | -74 | -20 |
| Free Cash Flow | -29,350 | -29,900 | -11,852 | -7,548 | -4,462 |